When Cosmetic Injectables Stop Being the Answer

When this question matters

For most patients on a maintenance cosmetic injectable rhythm, treatment continues to provide value year after year and the question of stopping does not arise. For a meaningful subset of patients, however, there is a point where continued treatment is no longer the appropriate intervention. Recognising that point and making an informed decision about how to respond is part of the long horizon clinical relationship that Core Aesthetics structures with patients.

This page is for patients who are starting to wonder whether cosmetic injectable treatment is still serving them, for patients reaching the Reassessment phase of the Core Longevity Plan, and for patients whose life circumstances have changed in ways that warrant rethinking their treatment relationship. It is not advocacy for stopping; it is honest engagement with a question that some patients face.

The patterns that suggest reassessment

Several patterns recur in patients for whom continued cosmetic injectable treatment is no longer the right answer.

Diminishing benefit relative to commitment: the patient is investing time and money in maintenance treatment but the visible benefit has reduced. This can reflect cumulative effects that have plateaued, or it can reflect that continued treatment is producing smaller marginal gains than earlier treatments did.

Structural changes exceed injectable scope: the patient’s anatomical changes have progressed to a point where filler and anti-wrinkle treatment can no longer meaningfully address them. Significant skin laxity, jowl prominence, neck area changes, and eyelid changes can all reach a point where surgical intervention is the more appropriate intervention layer if the patient wants substantial change.

Cumulative pattern that no longer reflects current goals: years of additive treatment have produced an outcome the patient now reassesses. The face has been gradually committed to a particular trajectory that may not align with where the patient wants to be now. This can warrant comprehensive replanning rather than continued addition.

Priorities have shifted: the patient’s relationship with their own appearance has changed. Some patients reach a point where continued cosmetic intervention no longer aligns with how they want to engage with ageing. This is a values question rather than a clinical question, and it is legitimate.

Time or financial commitment no longer fits: life circumstances have changed in ways that make ongoing maintenance harder to sustain. Career changes, retirement, family changes, or competing priorities can warrant reassessment of the maintenance rhythm.

Health changes: new medical conditions or medications can affect treatment suitability. Some patients should pause or stop treatment for clinical reasons that the consultation surfaces.

What the consultation conversation looks like

Reassessment consultations are structured differently from new treatment consultations. The discussion engages with the patient’s current relationship with their treatment, what has changed since the last comprehensive review, what the patient is now experiencing or noticing, and what the realistic options are going forward.

The conversation can result in several different recommendations. Continue current rhythm: the assessment supports continuing what the patient has been doing. Modify rhythm: the maintenance schedule, dosing, or area focus changes. Pause for a defined period: the patient takes a 6-12 month gap to let existing treatment settle and to see what their face looks like in its current baseline. Selective dissolution and replanning: specific older filler is dissolved to allow a fresh treatment approach. Substantial replanning: the patient and the clinic agree on a substantively different approach going forward. Stop treatment entirely: the patient decides cosmetic injectable treatment is no longer the right approach.

All six outcomes are legitimate. The consultation supports the patient through whichever conversation reflects their actual situation rather than advocating a particular outcome.

The "stop entirely" decision specifically

Patients who choose to stop cosmetic injectable treatment entirely have several options for how to do so. The choice depends on their preferences and clinical situation.

Gradual transition: the patient stops booking maintenance appointments. Existing filler resolves naturally over months to years. anti-wrinkle treatment effects wear off over months. The face transitions to its new baseline gradually. This is the simplest approach and works well for many patients.

Active dissolution: the patient dissolves existing filler in a focused approach over one or two appointments. The transition to baseline is faster but requires the dissolution itself, which is a separate procedure with its own recovery profile. This suits patients who want to see their baseline quickly or who have specific concerns about existing filler that they want to address before stopping.

Phased approach: the patient stops anti-wrinkle treatment immediately, lets that wear off naturally, then assesses whether dissolution of remaining filler is also wanted. This staged approach gives the patient time to live with each change and decide on the next step.

The consultation supports whichever approach the patient prefers. The clinic does not advocate for any particular path through the stopping decision; the patient’s preferences guide the planning.

What patients often experience after stopping

Patients who stop cosmetic injectable treatment commonly report several patterns of experience.

Surprise at how their face looks at baseline. Some patients have not seen their untreated face for many years and the baseline is unfamiliar. Some find this unsettling for a period before adapting; others find it positive. The adaptation typically takes weeks to months.

Reduced time and financial commitment. The patient no longer needs to plan around maintenance appointments. This typically feels positive, particularly for patients who had been finding the maintenance commitment disproportionate to the benefit.

Continued ageing visible without the treatment offset. The face continues to age and now the patient sees that ageing without the treatment that previously softened it. Some patients find this acceptable as part of their reorientation to natural ageing; others find it prompts reconsideration of stopping.

Some patients return to treatment after a period of stopping. The clinical record from the prior treatment relationship informs the resumption; the patient does not need to start from scratch. The clinic supports both stopping and returning without judgement either way.

When stopping is not the right decision

Some patients consider stopping for reasons that may not actually warrant stopping. Recognising these patterns can help patients make informed decisions.

Acute disappointment with a recent treatment outcome: a single treatment that did not produce the expected result is not necessarily a reason to stop ongoing treatment. The 2-week review and any necessary adjustment can address the immediate concern; broader stopping may be a reaction rather than a considered decision.

Temporary financial pressure: cost concerns may warrant pausing treatment for a defined period rather than stopping entirely. The maintenance rhythm can resume when finances allow.

Pressure from others: friends, family, or partner attitudes about cosmetic injectable treatment can influence the patient’s consideration of stopping. The decision should reflect the patient’s own assessment rather than external pressure.

Comparison to others: comparing one’s own treatment outcome to heavily edited social media images, or to friends who have very different anatomy or treatment histories, can produce dissatisfaction that does not reflect a real problem. Recalibrating expectations rather than stopping treatment may be the more appropriate response.

Clinical accountability and how this guide is reviewed

The clinical content on this page is written and reviewed by Corey Anderson, AHPRA registered nurse (NMW0001047575). The content reflects how Core Aesthetics frames this clinical conversation in practice. Results vary between individuals; the descriptions on this page refer to typical patterns rather than what every patient will experience.

Specific to stopping treatment content: this page exists because honest engagement with the question of stopping is part of the long horizon clinical relationship Core Aesthetics structures with patients. The consultation supports the patient’s decision regardless of which direction it goes; the clinic does not pursue patients to continue treatment that no longer serves them.

Patients can verify Corey Anderson’s AHPRA registration on the public register at ahpra.gov.au using number NMW0001047575. The Core Aesthetics clinic operates from 12A Atherton Road, Oakleigh VIC 3166, by consultation appointment. All new patient treatment at Core Aesthetics follows a structured clinical consultation, consistent with the September 2025 AHPRA cosmetic procedures guidelines. The team page covers the practitioner background.